Evaluating treatment effectiveness: Complementing RCTs with real-world data
As the need for RWD increases, especially for post-COVID-19 pandemic decision-making, ensuring high data quality and appropriate study design is critical. Proper evaluation of RWD sources enhances the credibility of findings and supports their use in meta-analyses, clinical guidelines, and healthcare policy.
Authors
- Stephanie H. Read (ORCID: https://orcid.org/0000-0002-2087-7358)
- Christina G. Rivera (ORCID: https://orcid.org/0000-0002-8308-3264)
- André C. Kalil (ORCID: https://orcid.org/0000-0002-6489-6294)
- Essy Mozaffari
Institutions
- Mayo Clinic in Arizona (US)
- Gilead Sciences (Australia) (AU)
- University of Nebraska Medical Center (US)
Publication Details
- Journal
- American Journal of Health-System Pharmacy
- Published
- 2026-02-05
- DOI
- https://doi.org/10.1093/ajhp/zxag035
- Primary Topic
- Meta-analysis and systematic reviews
- Type
- article
- Field-Weighted Citation Impact
- 0.00